Cure Duchenne

Profile Current (Last updated: Jan 08, 2026 )

Current Fiscal Year

Fiscal Year Start Date: January 1, 2025

Fiscal Year End Date: December 31, 2025

Projected Revenue: $11,099,247

Projected Expense: $10,854,979

Revenue vs. Expense ($)
Expense Breakdown: 2024 (%)
Administration Expense 0.2%
Program Expense 80.4%
Fundraising Expense 29.1%
Expense Breakdown: 2023 (%)
Administration Expense 7.5%
Program Expense 81.7%
Fundraising Expense 10.8%
Expense Breakdown: 2022 (%)
Administration Expense 13.4%
Program Expense 74.8%
Fundraising Expense 11.8%

990 Tax Form Newest 990 Year opens each June

Tax Year 2024 Form 990 (Fiscal Year ending in 2024) Download
Tax Year 2023 Form 990 (Fiscal Year ending in 2023) Download
Tax Year 2022 Form 990 (Fiscal Year ending in 2022) Download
Tax Year 2021 Form 990 (Fiscal Year ending in 2021) Download

Prior Three Years Total Revenue and Expense Totals

Fiscal Year 2024 2023 2022
Total Revenue $3,941,885 $7,357,938 $5,751,368
Total Expenses $9,167,617 $10,247,154 $9,005,616

Prior Three Years Revenue Sources

Fiscal Year 2024 2023 2022
Foundation and Corporation Contributions - $4,359,147 $978,714
Government Contributions - - -
Federal - - -
State - - -
Local - - -
Unspecified - - -
Individual Contributions - - -
Indirect Public Support - - -
Earned Revenue - - -
Investment Income, Net of Losses - $549,583 $147,656
Membership Dues - - -
Special Events - $2,068,014 $4,657,926
Revenue In-Kind - - -
Other Revenue $2,380,390 $1,117,110 $395,643

Prior Three Years Expense Allocations by Type

Fiscal Year 2024 2023 2022
Program Expense $7,366,415 $8,370,237 $6,736,726
Administration Expense $15,125 $770,691 $1,202,426
Fundraising Expense $2,664,101 $1,106,226 $1,066,464
Payments to Affiliates - - -
Total Revenue/Total Expenses 0.43 0.72 0.64
Program Expense/Total Expenses 80% 82% 75%
Fundraising Expense/Total Revenue 68% 15% 19%

Prior Three Years Assets and Liabilities

Fiscal Year 2024 2023 2022
Total Assets $30,906,923 $27,086,351 $28,410,543
Current Assets $2,931,152 $2,926,565 $8,879,454
Long-Term Liabilities $84,599 - -
Current Liabilities $163,265 $256,435 $310,658
Total Net Assets $30,659,059 $26,829,916 $28,099,885

Short Term Solvency

Fiscal Year 2024 2023 2022
Current Assets/Current Liabilities 17.95 11.41 28.58

Long Term Solvency

Fiscal Year 2024 2023 2022
Long Term Liabilities/Total Assets 0% - -

Endowment/Capital Campaigns

Are you currently in a Capital Campaign? -

CONTACT

Cure Duchenne

100 Bayview Circle
Suite 5600
Newport Beach, CA 92660

nancy@cureduchenne.org

Phone: 1.95E+13

www.cureduchenne.org